- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Lyka Labs Limited has announced a board meeting on March 4, 2025, to discuss the proposed Scheme of Amalgamation with Lyka Exports Limited. The meeting aims to gain approval from unsecured creditors for the merger, which is expected to enhance operational efficiency, achieve cost savings, and strengthen financial positioning by merging similar business activities. This strategic move is anticipated to create a more competitive entity with better cash flow management, benefiting shareholders of both companies. Investor sentiment may see a positive outlook as this merger aligns with growth strategies in the pharmaceutical sector.